Rubicon Genomics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Rubicon Genomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011202
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rubicon Genomics Inc (Rubicon Genomics), a subsidiary of the Takara Bio Group is a provider of pre-analytical amplification technologies. The company offers various types of kits for whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, copy number variation (CNV) analysis, Aneuploidy, circulating tumor deoxyribose nucleic acid (ctDNA) analysis, and gene expression analysis. It employs high sensitivity ligation-based amplification, and quasi-random primed linear amplification technologies in its sequencing kits. Rubicon Genomics’ sequencing kits find applications in Formalin-fixed, paraffin-embedded (FFPE) DNA sequencing, DNA sequencing, ribose nucleic acid (RNA) sequencing, pre-implantation genetic screening and diagnosis (PGS, PGD), and chromatin immunoprecipitation sequencing (ChIP-seq). Rubicon Genomics is headquartered in Ann Arbor, Michigan, the US.

Rubicon Genomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rubicon Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Rubicon Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Rubicon Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Rubicon Genomics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Rubicon Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Rubicon Genomics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Rubicon Genomics Raises USD2 Million in Venture Financing 10
Partnerships 11
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 11
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 12
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 13
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 14
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 15
New England Biolabs Enters Into Co-Marketing Agreement With Rubicon Genomics 16
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 17
Acquisition 18
Takara Bio Acquires Rubicon Genomics for USD75 Million 18
Rubicon Genomics Inc – Key Competitors 19
Rubicon Genomics Inc – Key Employees 20
Rubicon Genomics Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Product News 22
Nov 07, 2016: Rubicon Genomics to Present Data on New Thruplex Enrichment Kit at AMP 2016 Annual Meeting; Also Named 2017 “Company to Watch” Finalist 22
Other Significant Developments 23
Dec 21, 2016: Rubicon Genomics Signs Supply Agreement With Agilent Technologies For Its PicoPLEX WGA Kit 23
Aug 17, 2016: Rubicon Genomics reports robust Sales Growth in 2016 and announces Early Access Program for Thruplex Tag-Seq Kits 24
Apr 12, 2016: Rubicon Genomics Expands Asia Distribution; 2016 AACR Data Presentation Shows Utility of ThruPLEX Plasma-seq Cell-Free NGS Libraries From Liquid Biopsies 25
Jan 11, 2016: Rubicon Genomics Adds New Distributors as Product Sales Continued to Accelerate in 2015 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Rubicon Genomics Inc, Medical Equipment, Key Facts 2
Rubicon Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Rubicon Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Rubicon Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Rubicon Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Rubicon Genomics Inc, Deals By Market, 2011 to YTD 2017 8
Rubicon Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Rubicon Genomics Raises USD2 Million in Venture Financing 10
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 11
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 12
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 13
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 14
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 15
New England Biolabs Enters Into Co-Marketing Agreement With Rubicon Genomics 16
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 17
Takara Bio Acquires Rubicon Genomics for USD75 Million 18
Rubicon Genomics Inc, Key Competitors 19
Rubicon Genomics Inc, Key Employees 20

★海外企業調査レポート[Rubicon Genomics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Quantum Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Quantum Energy Inc (Quantum Energy), formerly MJD Solutions Inc is an oil and gas company. The company operates in refinery development, land holdings, oil and natural gas exploration, drilling, well completion, and fuel distribution in the Bakken field. Its products lines include ngl’s, gas …
  • Kezar Life Sciences Inc (KZR):製薬・医療:M&Aディール及び事業提携情報
    Summary Kezar Life Sciences Inc (Kezar Life Sciences) is a clinical-stage biotechnology company that discovers and develops small molecule therapies to treat autoimmunity and cancer. The company’s lead product candidate, KZR-616, an immunoproteasome inhibitor intended for the treatment of various au …
  • Varian Medical Systems Inc (VAR):企業の財務・戦略的SWOT分析
    Varian Medical Systems Inc (VAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • SSA Marine Inc:企業の戦略的SWOT分析
    SSA Marine Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Theraclone Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Theraclone Sciences Inc (Theraclone) is a biotech company that develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The company offers development programs on infectious disease which include novel antibodies to fight pandemic and seasonal influenza. It …
  • Bulgarian Telecommunications Company (VIVACOM):企業の戦略的SWOT分析
    Bulgarian Telecommunications Company (VIVACOM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Toleranzia AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Toleranzia AB (Toleranzia) is a drug developer that utilizes immune system’s intrinsic power to treat autoimmune diseases. The company offers products and technologies including Re-Tolerogen for the treatment of autoimmune diseases. Its Re-Tolerogen platform technology is a fusion protein fo …
  • Veolia Environnement S.A.:企業の戦略・SWOT・財務分析
    Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report Summary Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Spicers Limited (SRS):企業の財務・戦略的SWOT分析
    Spicers Limited (SRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Jagatjit Industries Limited:企業の戦略・SWOT・財務情報
    Jagatjit Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Jagatjit Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • DKSH Holding Ltd. (DKSH):企業の財務・戦略的SWOT分析
    DKSH Holding Ltd. (DKSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tetra Pak International SA:企業の戦略・SWOT・財務分析
    Tetra Pak International SA - Strategy, SWOT and Corporate Finance Report Summary Tetra Pak International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ube Industries, Ltd.:企業の戦略・SWOT・財務情報
    Ube Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ube Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tecpetrol SA:企業の戦略的SWOT分析
    Tecpetrol SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Marriott Vacations Worldwide Corp:企業の戦略・SWOT・財務分析
    Marriott Vacations Worldwide Corp - Strategy, SWOT and Corporate Finance Report Summary Marriott Vacations Worldwide Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PricewaterhouseCoopers International Limited:企業の戦略・SWOT・財務情報
    PricewaterhouseCoopers International Limited - Strategy, SWOT and Corporate Finance Report Summary PricewaterhouseCoopers International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Mamee-Double Decker (M) Berhad:企業の戦略的SWOT分析
    Mamee-Double Decker (M) Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Medigard Ltd (MGZ)-医療機器分野:企業M&A・提携分析
    Summary Medigard Ltd (Medigard), formerly Medisafe Instruments Pty Ltd is a medical device company that designs and develops retractable safety medical devices. The company offers products such as auto-retractable syringe, manual retractable syringe, blood collection device, intravenous valve and fl …
  • Grupa Lotos SA (LTS):石油・ガス:M&Aディール及び事業提携情報
    Summary Grupa Lotos S.A. (Grupa Lotos) is an integrated energy company. The company carries out various activities such as the extraction and refining of crude oil; processing of petroleum into finished products; and the wholesale and retail distribution and sale of petroleum products. Its product p …
  • Nanosonics Ltd (NAN):企業の財務・戦略的SWOT分析
    Nanosonics Ltd (NAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆